aTyr Pharma Inc (LIFE)

Profile

• URL: https://www.atyrpharma.com
• Investor Relations URL: http://atyrpharma.investorroom.com/
• HQ State/Province: California
• Sector: Healthcare
• Industry: Biotechnology
• Equity Style: Small Cap/Value
• Next Earnings Release: N/A
• Last Earnings Release: Aug. 10, 2018
• Next Ex-Dividend Date: N/A
• Last Ex-Dividend Date: N/A
• Description: aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology. It has discovered approximately 300 Physiocrines, a class of naturally occurring human proteins that it promotes homeostasis, a fundamental process of restoring stressed or diseased tissue to a healthier state. The company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component. Business activity is primarily conducted through the United States.